A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment

NCT04829318 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Esketamine
DRUG: SSRI/SNRI

Sponsor

Janssen-Cilag Ltd.